COPENHAGEN, Denmark, Sept. 4, 2026 /PRNewswire/ -- Novonesis will expand its facility in Patalganga and build one of the world's most advanced enzyme production facilities. The €600 million investment will increase Novonesis' production capacity to meet rising worldwide demand for the company's biosolutions and strengthen the flexibility and resilience of its global supply network.

The Patalganga expansion is a milestone in Novonesis' strategy and key to achieving the company's growth ambitions. The facility, which is expected to be fully operational in 2030, will produce enzymes for a broad range of industries, including biofuels, household care, and food and beverages.

Ester Baiget, President & CEO:

"This is an important step in executing our strategy and reflects our continued commitment to investing for sustainable growth. The expansion strengthens our ability to support customers around the world and enables us to continue creating long-term value for our shareholders."

This state-of-the-art facility will be integrated into the company's global production footprint and bring Novonesis closer to customers across the Middle East, India, and Africa. These markets represent an important and growing part of the company's business and are expected to grow faster than developed markets in the coming years.

Anders Lund, Chief Operating Officer:

"As demand for biosolutions continues to grow across industries and regions, expanding our global production capacity is a priority. The Patalganga expansion will strengthen our scale, operational resilience, efficiency, and supply flexibility. Just as importantly, it brings us closer to customers in key growth markets, enabling us to meet their expectations and deliver on our long-term growth targets."

Strengthening global production capabilities

Patalganga is part of a series of investments Novonesis has made to strengthen its global production setup and serve customers more effectively. Facilities in Rayong, Thailand; Franklinton, North Carolina; Taicang, China; Araucaria, Brazil; and West Allis, Wisconsin, have also been expanded as part of this effort. The investments align with the company's strategy and previously communicated capital expenditure plans.

Setting a new standard for sustainable biosolutions production

The Patalganga facility will be built to use less water and energy. Freshwater recycling will reduce the amount of water the site draws, while integrated heat pumps will lower the energy required to operate it. Together, these measures will put the facility on a path toward lower Scope 1 and 2 emissions.
"Every facility we build should produce more with less. Patalganga brings together what we have learned across our production footprint and takes us another step toward zero-emission production," says Anders Lund.

About Novonesis

Novonesis is leading the era of biosolutions.

By leveraging the power of microbiology with science, we transform the way the world produces, consumes and lives. In more than 30 industries around the world, our biosolutions are already creating value for thousands of customers and benefiting the planet.

Our foundation is built on the combined 100+ years of legacies of Novozymes and Chr. Hansen — two Danish-based pioneers in microbial science, fermentation, and enzyme innovation who joined forces in 2024 under the name 'Novonesis', which means new beginning.

Our 11,000 people worldwide work closely with our partners and customers to transform business with biology.